Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Jacopo Mariotti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology/Hematology, IRCCS Humanitas Research Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Brentuximab Vedotin, Salvage Therapy, Hodgkin Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health's 'Ricerca Corrente', IRCCS Humanitas Research Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology/Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Biostatistic Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
ORCID-Profile: Jacopo Mariotti, Daniele Mannina
Förderung
- Italian Ministry of Health's 'Ricerca Corrente'
- IRCCS Humanitas Research Hospital
Zitieren
APA
Mariotti, J., Pinton, C., Giordano, L., Taurino, D., Sarina, B., De Philippis, C., Mannina, D., Tentori, C., Santoro, A., & Bramanti, S. (2025). Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis. British Journal of Haematology. https://doi.org/10.1111/bjh.70091
Vancouver
Mariotti J, Pinton C, Giordano L, Taurino D, Sarina B, De Philippis C, et al. Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis. British Journal of Haematology. 2025. doi:10.1111/bjh.70091
BibTeX
@article{Mariotti2025,
author = {Mariotti, Jacopo and Pinton, Chiara and Giordano, Laura and Taurino, Daniela and Sarina, Barbara and De Philippis, Chiara and Mannina, Daniele and Tentori, Cristina and Santoro, Armando and Bramanti, Stefania},
title = {Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70091}
}
EUVIMED